VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5214AA: VAERS reports

34 VAERS reports list lot U5214AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2015-05-07 and 2017-07-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
24%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3728%
General / Systemic (non-local)3023%
Neurological1814%
Allergic / Anaphylactic108%
Musculoskeletal108%
Gastrointestinal97%
Respiratory65%
Cardiac / Cardiovascular54%
Dermatological (non-injection-site)43%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York4
Virginia3
Utah3
Pennsylvania3
Florida3
Ohio3
Connecticut2
New Jersey2
Massachusetts2
Wisconsin2
California2
Tennessee1

Reports by month received

2015-052
2015-066
2015-079
2015-084
2015-092
2015-104
2015-112
2016-031
2016-042
2017-041
2017-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.